SCHEMBL10238030

SCHEMBL10238030

Cc1sc(-c2cccc(Cl)c2Cl)nc1C1C(=O)[C@@H]2CC[C@@H](C2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 4/20 0.44
▸ SLC6A3 Q01959 1/20 0.40
▸ PTPN11 Q06124 12/20 0.38
▸ ACHE P22303 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10238058 0.91 ALDH1A1 (0.37) HTR2CACHE
SCHEMBL10238122 0.85 SLC6A3 (0.38) HTR2CSLC6A3PTPN11ACHE
SCHEMBL16215989 0.85 SLC6A3 (0.38) HTR2CSLC6A3PTPN11ACHE
SCHEMBL10238062 0.81 ACHE (0.39) SLC6A3ACHE
SCHEMBL10237900 0.81 SHMT1 (0.41) SLC6A3ACHE
SCHEMBL10237929 0.79 ACHE (0.39) SLC6A3ACHE
SCHEMBL10237934 0.78 RAB9A (0.40) SLC6A3ACHE
SCHEMBL10238017 0.78 ALDH1A1 (0.41) ACHE
SCHEMBL10237915 0.78 SLC6A3 (0.39) SLC6A3ACHE
SCHEMBL16215997 0.78 SLC6A3 (0.39) SLC6A3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176222-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2014-11-05 — — EP disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-8541594-B2 — — 2013-09-24 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed
US-20120040826-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2012-02-16 — — US disclosed
WO-2009015877-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2009-02-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040826-A1 NOVEL HERBICIDES DDT, HDHD5, DDC HTR2C 399/4885SLC6A3 858/4885PTPN11 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback